Answers are grounded in this paper and cite their sources.
Cohort study shows poor CD4+ T cell responses post-vaccination in older adults, indicating the need for improved vaccines.
Description Influenza-related illness is a significant cause of morbidity and mortality in older adults. With age comes decreased antibody responses, reduced naïve thymic output, and increased T cell senescence. While recent vaccine formulations have improved the magnitude of antibody responses in older adults, this population remains at an increased risk of severe influenza-related illness. In a cohort of 15 older adults (over 65) and 32 younger adults (under 45), we investigated vaccine-elicited B and CD4+ T cell responses. At day 28 post-vaccination, both age groups mounted similar antibody responses and achieved equivalent titers for all vaccine antigens. At day 7 post-vaccination, younger adults had increased frequencies of H1N1 and H3N2 reactive OX40+ CD40L+ memory CD4+ T cells compared to older adults. Furthermore, immune profiling data revealed younger adults had higher frequencies of circulating T follicular helper (cTfh) cells pre-vaccination and increased frequencies of activated ICOS+ CD38+ cTfh cells post-vaccination. Lastly, single-cell sequencing revealed older adults had reduced STAT1-driven antiviral gene profiles associated with activated T cell populations following stimulation with inactivated virus. Our data indicate that older adults have poor CD4+ T helper responses after vaccination despite productive antibody responses, which highlights the need to further investigate the effects of aging on CD4+ T cell responses to improve future vaccine efforts.
No takes yet. Share an insight, caveat, or question.
Oakes et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: